Review



a2bp1 polyclonal antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech a2bp1 polyclonal antibody
    Copy Number Variation of <t>RBFOX1</t> and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.
    A2bp1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bp1+polyclonal+antibody/A2BP1+Antibody/pmc12099144-73-0-3
    Average 93 stars, based on 4 article reviews
    a2bp1 polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer"

    Article Title: The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer

    Journal: Technology in Cancer Research & Treatment

    doi: 10.1177/15330338251333695

    Copy Number Variation of RBFOX1 and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.
    Figure Legend Snippet: Copy Number Variation of RBFOX1 and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.

    Techniques Used:

    Characteristics of RBFOX1 mRNA in Colorectal Cancer. A. Correlation Analysis of Total RBFOX1 Copy Number Variation and RBFOX1 mRNA Expression. B. Differences in RBFOX1 mRNA Expression Among the Four Groups, with Significant Differences Between Groups A And C (**** Represent P < 0.0001), and Significant Differences Between Groups C And D (*** Denotes P < 0.001). C-F. Correlation Analysis of Copy Number Variation and Corresponding mRNA Expression in Each Group Among the Four Groups., C: (Group A–High–Level Copy Number Deletions Group), D(Group B– Represent Low-Level Deletion Group), E(Group C– Normal Group), F(Group D –Copy Number Amplification Group). G. Relative mRNA Expression of RBFOX1 in Colon Adenocarcinoma and Rectal Adenocarcinoma, Indicating that RBFOX1 mRNA Expression in Colorectal Cancer is Lower than in Normal Tissues. H. Correlation between BRAF Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues. I. Correlation Between PIK3CA Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues.
    Figure Legend Snippet: Characteristics of RBFOX1 mRNA in Colorectal Cancer. A. Correlation Analysis of Total RBFOX1 Copy Number Variation and RBFOX1 mRNA Expression. B. Differences in RBFOX1 mRNA Expression Among the Four Groups, with Significant Differences Between Groups A And C (**** Represent P < 0.0001), and Significant Differences Between Groups C And D (*** Denotes P < 0.001). C-F. Correlation Analysis of Copy Number Variation and Corresponding mRNA Expression in Each Group Among the Four Groups., C: (Group A–High–Level Copy Number Deletions Group), D(Group B– Represent Low-Level Deletion Group), E(Group C– Normal Group), F(Group D –Copy Number Amplification Group). G. Relative mRNA Expression of RBFOX1 in Colon Adenocarcinoma and Rectal Adenocarcinoma, Indicating that RBFOX1 mRNA Expression in Colorectal Cancer is Lower than in Normal Tissues. H. Correlation between BRAF Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues. I. Correlation Between PIK3CA Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues.

    Techniques Used: Expressing, Amplification, Mutagenesis

    Immunofluorescence Analysis of RBFOX1 Protein in Tumor Cells. A. Immunofluorescence from the Human Protein Atlas Database shows that RBFOX1 has Different Nuclear-Cytoplasmic Distribution Characteristics in Cancer Cells of Three Different Tissues. ( https://www.proteinatlas.org/search/RBFOX1 ) B. COSMIC Cancer Cell Engineering shows Copy Number Deletions in Multiple Colorectal Cancer Cells. C. Immunofluorescence shows that RBFOX1 Protein is Mainly Distributed in the Nucleus of Well-Differentiated Tumor Cells HT-29 and SW480, While in Poorly Differentiated HCT116, The Protein shows Nuclear-Cytoplasmic Distribution Characteristics.
    Figure Legend Snippet: Immunofluorescence Analysis of RBFOX1 Protein in Tumor Cells. A. Immunofluorescence from the Human Protein Atlas Database shows that RBFOX1 has Different Nuclear-Cytoplasmic Distribution Characteristics in Cancer Cells of Three Different Tissues. ( https://www.proteinatlas.org/search/RBFOX1 ) B. COSMIC Cancer Cell Engineering shows Copy Number Deletions in Multiple Colorectal Cancer Cells. C. Immunofluorescence shows that RBFOX1 Protein is Mainly Distributed in the Nucleus of Well-Differentiated Tumor Cells HT-29 and SW480, While in Poorly Differentiated HCT116, The Protein shows Nuclear-Cytoplasmic Distribution Characteristics.

    Techniques Used: Immunofluorescence

    Immunohistochemical Analysis of RBFOX1 Expression Level in Normal and Cancerous Colorectal Tissues. A. Immunohistochemical Results from The Human Protein Atlas Database Show that the Protein is Mainly Distributed in the Glandular Cells of the Normal Intestine and shows Low Cytoplasmic Distribution Characteristics, But the Expression of this Protein is not Detected in Colorectal Cancer Tissues, Here are Two Representative Tissues. N1958 Representative an Immunohistochemical Results of RBFOX1 of 84 Years Old Female Patient in Normal Colon Tissue, 1958 is the Patient ID, N1857 Representative an Immunohistochemical Results of RBFOX1 of 47 Years Old Male Patient in Normal Colon Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 70 Years Old Female Patient in Adenocarcinoma Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 82 Years Old Female Patient in Colon Adenocarcinoma Tissue. ( https://www.proteinatlas.org/search/RBFOX1 ). B. Immunohistochemical Results of RBFOX1 in Two High-Throughput Pathological Tissue Chips (Consisting of 69 Colorectal Cancer Tissues). C. A Normal Brain Sample was Used as a Positive Control., On the Left is a 100x Microscopic Image of the Brain, And on the Right is a 200x Magnified Image of a Localized Area on the Left. D. Immunohistochemical Results of RBFOX1 in Intestinal Tissue from a Case of slow Transit Constipation Undergoing Total Colectomy. E. Immunohistochemical Results of RBFOX1 in Three Right-Sided Colorectal Cancers and Adjacent Tissues. N Means Normal, C Means Cancer.
    Figure Legend Snippet: Immunohistochemical Analysis of RBFOX1 Expression Level in Normal and Cancerous Colorectal Tissues. A. Immunohistochemical Results from The Human Protein Atlas Database Show that the Protein is Mainly Distributed in the Glandular Cells of the Normal Intestine and shows Low Cytoplasmic Distribution Characteristics, But the Expression of this Protein is not Detected in Colorectal Cancer Tissues, Here are Two Representative Tissues. N1958 Representative an Immunohistochemical Results of RBFOX1 of 84 Years Old Female Patient in Normal Colon Tissue, 1958 is the Patient ID, N1857 Representative an Immunohistochemical Results of RBFOX1 of 47 Years Old Male Patient in Normal Colon Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 70 Years Old Female Patient in Adenocarcinoma Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 82 Years Old Female Patient in Colon Adenocarcinoma Tissue. ( https://www.proteinatlas.org/search/RBFOX1 ). B. Immunohistochemical Results of RBFOX1 in Two High-Throughput Pathological Tissue Chips (Consisting of 69 Colorectal Cancer Tissues). C. A Normal Brain Sample was Used as a Positive Control., On the Left is a 100x Microscopic Image of the Brain, And on the Right is a 200x Magnified Image of a Localized Area on the Left. D. Immunohistochemical Results of RBFOX1 in Intestinal Tissue from a Case of slow Transit Constipation Undergoing Total Colectomy. E. Immunohistochemical Results of RBFOX1 in Three Right-Sided Colorectal Cancers and Adjacent Tissues. N Means Normal, C Means Cancer.

    Techniques Used: Immunohistochemical staining, Expressing, High Throughput Screening Assay, Positive Control



    Similar Products

    93
    Proteintech a2bp1 polyclonal antibody
    Copy Number Variation of <t>RBFOX1</t> and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.
    A2bp1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bp1+polyclonal+antibody/A2BP1+Antibody/pmc12099144-73-0-3
    Average 93 stars, based on 1 article reviews
    a2bp1 polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit polyclonal anti rbfox1 antibody
    Copy Number Variation of <t>RBFOX1</t> and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.
    Rabbit Polyclonal Anti Rbfox1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bp1+polyclonal+antibody/A2BP1+Antibody/pmc07946914__41467_2021_21623_MOESM2_ESM-13-90-94
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal anti rbfox1 antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Copy Number Variation of RBFOX1 and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.

    Journal: Technology in Cancer Research & Treatment

    Article Title: The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer

    doi: 10.1177/15330338251333695

    Figure Lengend Snippet: Copy Number Variation of RBFOX1 and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.

    Article Snippet: A2BP1 Polyclonal antibody (Proteintech, USA, 22647-1-AP) was added dropwise and incubated at 37 °C for 1 h. The liquid was poured off, and the sections were rinsed with PBS three times.

    Techniques:

    Characteristics of RBFOX1 mRNA in Colorectal Cancer. A. Correlation Analysis of Total RBFOX1 Copy Number Variation and RBFOX1 mRNA Expression. B. Differences in RBFOX1 mRNA Expression Among the Four Groups, with Significant Differences Between Groups A And C (**** Represent P < 0.0001), and Significant Differences Between Groups C And D (*** Denotes P < 0.001). C-F. Correlation Analysis of Copy Number Variation and Corresponding mRNA Expression in Each Group Among the Four Groups., C: (Group A–High–Level Copy Number Deletions Group), D(Group B– Represent Low-Level Deletion Group), E(Group C– Normal Group), F(Group D –Copy Number Amplification Group). G. Relative mRNA Expression of RBFOX1 in Colon Adenocarcinoma and Rectal Adenocarcinoma, Indicating that RBFOX1 mRNA Expression in Colorectal Cancer is Lower than in Normal Tissues. H. Correlation between BRAF Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues. I. Correlation Between PIK3CA Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues.

    Journal: Technology in Cancer Research & Treatment

    Article Title: The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer

    doi: 10.1177/15330338251333695

    Figure Lengend Snippet: Characteristics of RBFOX1 mRNA in Colorectal Cancer. A. Correlation Analysis of Total RBFOX1 Copy Number Variation and RBFOX1 mRNA Expression. B. Differences in RBFOX1 mRNA Expression Among the Four Groups, with Significant Differences Between Groups A And C (**** Represent P < 0.0001), and Significant Differences Between Groups C And D (*** Denotes P < 0.001). C-F. Correlation Analysis of Copy Number Variation and Corresponding mRNA Expression in Each Group Among the Four Groups., C: (Group A–High–Level Copy Number Deletions Group), D(Group B– Represent Low-Level Deletion Group), E(Group C– Normal Group), F(Group D –Copy Number Amplification Group). G. Relative mRNA Expression of RBFOX1 in Colon Adenocarcinoma and Rectal Adenocarcinoma, Indicating that RBFOX1 mRNA Expression in Colorectal Cancer is Lower than in Normal Tissues. H. Correlation between BRAF Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues. I. Correlation Between PIK3CA Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues.

    Article Snippet: A2BP1 Polyclonal antibody (Proteintech, USA, 22647-1-AP) was added dropwise and incubated at 37 °C for 1 h. The liquid was poured off, and the sections were rinsed with PBS three times.

    Techniques: Expressing, Amplification, Mutagenesis

    Immunofluorescence Analysis of RBFOX1 Protein in Tumor Cells. A. Immunofluorescence from the Human Protein Atlas Database shows that RBFOX1 has Different Nuclear-Cytoplasmic Distribution Characteristics in Cancer Cells of Three Different Tissues. ( https://www.proteinatlas.org/search/RBFOX1 ) B. COSMIC Cancer Cell Engineering shows Copy Number Deletions in Multiple Colorectal Cancer Cells. C. Immunofluorescence shows that RBFOX1 Protein is Mainly Distributed in the Nucleus of Well-Differentiated Tumor Cells HT-29 and SW480, While in Poorly Differentiated HCT116, The Protein shows Nuclear-Cytoplasmic Distribution Characteristics.

    Journal: Technology in Cancer Research & Treatment

    Article Title: The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer

    doi: 10.1177/15330338251333695

    Figure Lengend Snippet: Immunofluorescence Analysis of RBFOX1 Protein in Tumor Cells. A. Immunofluorescence from the Human Protein Atlas Database shows that RBFOX1 has Different Nuclear-Cytoplasmic Distribution Characteristics in Cancer Cells of Three Different Tissues. ( https://www.proteinatlas.org/search/RBFOX1 ) B. COSMIC Cancer Cell Engineering shows Copy Number Deletions in Multiple Colorectal Cancer Cells. C. Immunofluorescence shows that RBFOX1 Protein is Mainly Distributed in the Nucleus of Well-Differentiated Tumor Cells HT-29 and SW480, While in Poorly Differentiated HCT116, The Protein shows Nuclear-Cytoplasmic Distribution Characteristics.

    Article Snippet: A2BP1 Polyclonal antibody (Proteintech, USA, 22647-1-AP) was added dropwise and incubated at 37 °C for 1 h. The liquid was poured off, and the sections were rinsed with PBS three times.

    Techniques: Immunofluorescence

    Immunohistochemical Analysis of RBFOX1 Expression Level in Normal and Cancerous Colorectal Tissues. A. Immunohistochemical Results from The Human Protein Atlas Database Show that the Protein is Mainly Distributed in the Glandular Cells of the Normal Intestine and shows Low Cytoplasmic Distribution Characteristics, But the Expression of this Protein is not Detected in Colorectal Cancer Tissues, Here are Two Representative Tissues. N1958 Representative an Immunohistochemical Results of RBFOX1 of 84 Years Old Female Patient in Normal Colon Tissue, 1958 is the Patient ID, N1857 Representative an Immunohistochemical Results of RBFOX1 of 47 Years Old Male Patient in Normal Colon Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 70 Years Old Female Patient in Adenocarcinoma Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 82 Years Old Female Patient in Colon Adenocarcinoma Tissue. ( https://www.proteinatlas.org/search/RBFOX1 ). B. Immunohistochemical Results of RBFOX1 in Two High-Throughput Pathological Tissue Chips (Consisting of 69 Colorectal Cancer Tissues). C. A Normal Brain Sample was Used as a Positive Control., On the Left is a 100x Microscopic Image of the Brain, And on the Right is a 200x Magnified Image of a Localized Area on the Left. D. Immunohistochemical Results of RBFOX1 in Intestinal Tissue from a Case of slow Transit Constipation Undergoing Total Colectomy. E. Immunohistochemical Results of RBFOX1 in Three Right-Sided Colorectal Cancers and Adjacent Tissues. N Means Normal, C Means Cancer.

    Journal: Technology in Cancer Research & Treatment

    Article Title: The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer

    doi: 10.1177/15330338251333695

    Figure Lengend Snippet: Immunohistochemical Analysis of RBFOX1 Expression Level in Normal and Cancerous Colorectal Tissues. A. Immunohistochemical Results from The Human Protein Atlas Database Show that the Protein is Mainly Distributed in the Glandular Cells of the Normal Intestine and shows Low Cytoplasmic Distribution Characteristics, But the Expression of this Protein is not Detected in Colorectal Cancer Tissues, Here are Two Representative Tissues. N1958 Representative an Immunohistochemical Results of RBFOX1 of 84 Years Old Female Patient in Normal Colon Tissue, 1958 is the Patient ID, N1857 Representative an Immunohistochemical Results of RBFOX1 of 47 Years Old Male Patient in Normal Colon Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 70 Years Old Female Patient in Adenocarcinoma Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 82 Years Old Female Patient in Colon Adenocarcinoma Tissue. ( https://www.proteinatlas.org/search/RBFOX1 ). B. Immunohistochemical Results of RBFOX1 in Two High-Throughput Pathological Tissue Chips (Consisting of 69 Colorectal Cancer Tissues). C. A Normal Brain Sample was Used as a Positive Control., On the Left is a 100x Microscopic Image of the Brain, And on the Right is a 200x Magnified Image of a Localized Area on the Left. D. Immunohistochemical Results of RBFOX1 in Intestinal Tissue from a Case of slow Transit Constipation Undergoing Total Colectomy. E. Immunohistochemical Results of RBFOX1 in Three Right-Sided Colorectal Cancers and Adjacent Tissues. N Means Normal, C Means Cancer.

    Article Snippet: A2BP1 Polyclonal antibody (Proteintech, USA, 22647-1-AP) was added dropwise and incubated at 37 °C for 1 h. The liquid was poured off, and the sections were rinsed with PBS three times.

    Techniques: Immunohistochemical staining, Expressing, High Throughput Screening Assay, Positive Control